View Future GrowthInter Pharma 過去の業績過去 基準チェック /46Inter Pharmaの収益は年間平均-3.1%の割合で減少していますが、 Personal Products業界の収益は年間 増加しています。収益は年間7.2% 20.6%割合で 増加しています。 Inter Pharmaの自己資本利益率は6.3%であり、純利益率は5.9%です。主要情報-3.09%収益成長率-9.53%EPS成長率Personal Products 業界の成長3.67%収益成長率20.57%株主資本利益率6.30%ネット・マージン5.91%前回の決算情報31 Mar 2026最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • Mar 03Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026Inter Pharma Public Company Limited announced Annual dividend of THB 0.0730 per share payable on May 25, 2026, ex-date on May 06, 2026 and record date on May 07, 2026.お知らせ • Mar 02Inter Pharma Public Company Limited, Annual General Meeting, Apr 27, 2026Inter Pharma Public Company Limited, Annual General Meeting, Apr 27, 2026, at 14:00 SE Asia Standard Time.お知らせ • Feb 27Inter Pharma Public Company Limited Proposes to Omit Dividend Payment for the Year Ended December 31, 2024Inter Pharma Public Company Limited at its Annual General Meeting of Shareholders to be on April 26, 2024, proposed the allocation of net profit for the year ended December 31, 2024 amount of THB 1.2 Million as the Company's legal reserve and approve the omitted dividend payment for operating results in 2024 to be used as working capital of the Company.お知らせ • Feb 26Inter Pharma Public Company Limited, Annual General Meeting, Apr 28, 2025Inter Pharma Public Company Limited, Annual General Meeting, Apr 28, 2025, at 14:00 SE Asia Standard Time.お知らせ • Apr 27Inter Pharma Public Company Limited Approves Dividend for the Year 2023, Payable on May 24, 2024Inter Pharma Public Company Limited announced that at the AGM was held on April 26, 2024, the company approved the dividend payment in cash to shareholders at the rate of THB 0.0348 per share for the Year 2023. The Board also specified the date to determine the list of shareholders entitled to receive the dividend as May 8, 2024 (Record Date), with dividend payments scheduled on May 24, 2024.お知らせ • Mar 01+ 1 more updateInter Pharma Public Company Limited Proposes Dividend for the Year 2023, Payable on May 24, 2024Inter Pharma Public Company Limited proposed at its AGM to be held on April 26, 2024 to approve The dividend payment in cash to shareholders at the rate of THB 0.0348 per share, totalling not exceeding THB 12,963,714.2352. The Board also specified the date to determine the list of shareholders entitled to receive the dividend as May 8, 2024 (Record Date), with dividend payments scheduled on May 24, 2024.お知らせ • Jun 28+ 1 more updateInter Pharma Public Company Limited Announces CFO ChangesInter Pharma Public Company Limited announced the resignation of Mrs. Nattarin Polpuech as CFO effective June 23, 2023. The company also appointed Miss Chatkaew Krudkosol as Acting Chief Financial Officer effective June 23, 2023.お知らせ • Dec 03Inter Pharma Public Company Limited Announces Resignation of Terdkiat Prommool as DirectorInter Pharma Public Company Limited announced that Mr. Terdkiat Prommool has resigned from the Director of the Company due to his other business engagement, effective from December 1, 2022 onwards.お知らせ • Aug 11+ 1 more updateInter Pharma Public Company Limited announced that it has received THB 1.04314 billion in funding from Innobic LL Holding Company LimitedOn August 10, 2022 Inter Pharma Public Company Limited closed the transaction. The company issued 4,510,000 shares at a price of THB 14 each share for the gross proceeds of THB 1,043,140,000 to Innobic LL Holding Company Limited.お知らせ • Jul 22Inter Pharma Public Company Limited Approves Election of DirectorsInter Pharma Public Company Limited approved the appointment of Mrs. Apimon Posri, Mrs. Nattarin Polpuech and Ms. Chompunuch Meevang as Director, at the EGM held on July 20, 2022.お知らせ • Jul 05Inter Pharma Public Company Limited Announces Chief Financial Officer ChangesInter Pharma Public Company Limited announced that Ms. Supaporn Rerkpitakpanich, the former position of Chief Financial Officer has been changed to Group Accounting & Finance Director and will be responsible for the accounting and finance of the Group of Company. Also, Mrs. Nattarin Polpuech, former position Finance Manager will be replacing Ms. Supaporn's and become Chief Financial Officer, effective July 1, 2022 onwards.お知らせ • Feb 26+ 1 more updateInter Pharma Public Company Limited Proposes Omission of Dividend Payment for 2021of dividend payment approved to propose to the Shareholders' Meeting to consider and approve the omission of dividend payment for the operating results of the year 2021, due to the Company has plan for business expansion. Therefore, reserves must be set aside to support the expansion plan in order to create sustainable growth for the Company.お知らせ • Apr 27Inter Pharma Public Company Limited Approves Cash Dividends for 2020, Payable on May 18, 2020Inter Pharma Public Company Limited will pay cash dividends instead of stock dividend at the rate of THB 0.2234 per share. The record date for Dividend is set out on March 12, 2021 and the dividend will be paid on May 18, 2021.お知らせ • Feb 26Inter Pharma Public Company Limited, Annual General Meeting, Apr 26, 2021Inter Pharma Public Company Limited, Annual General Meeting, Apr 26, 2021, at 08:00 Coordinated Universal Time. Agenda: To certify the minutes of the Extraordinary General Meeting of Shareholders No. 1/2020; to acknowledge the issuance and offering of debentures in the amount not exceeding THB 300 million, provided the total debt burden of the Company at any given time must not exceed the amount of THB 460 million; to consider and approve the increase in the Company's registered capital to support the stock dividend payment; to consider and approve an amendment to Clause 4 of the Company's Memorandum of Association to reflect the increase in registered capital; to consider and approve the appointment of directors replacing those due to retire by rotation; to consider and approve the remuneration of directors for the year 2021; to consider and approve the appointment and remuneration of auditors for the year 2021; and to consider other matters (if any) e for 2021 Annual General of shareholder's Meeting is scheduled on April 12th, 2021. med accordingly,.お知らせ • Feb 10+ 1 more updateInter Pharma Public Company Limited (SET:IP) entered into an agreement to acquire Certain Assets of Teva Pharma (Thailand) Co., Ltd. from Teva Pharma (Thailand) Co., Ltd. for THB 160 million.Inter Pharma Public Company Limited (SET:IP) entered into an agreement to acquire Certain Assets of Teva Pharma (Thailand) Co., Ltd. from Teva Pharma (Thailand) Co., Ltd. for THB 160 million on February 8, 2021.お知らせ • Jan 31Inter Pharma Public Company Limited Notifies the Resignation of Mr. Amornsakdi Ketcharoon from Independent Director, Audit Committee, Chairman of the Nomination and Remuneration Committee and Corporate Governance and Sustainable Development Committee ,Effective from January 31, 2021Inter Pharma Public Company Limited notified the resignation of Mr. Amornsakdi Ketcharoon from Independent Director, Audit Committee, Chairman of the Nomination and Remuneration Committee and Corporate Governance and Sustainable Development Committee because of the individual duties. The resignation will be effective from January 31, 2021 onwards.お知らせ • Sep 26+ 1 more updateInterpharma Public Company Limited Announces Director ChangesInterpharma Public Company Limited announced the changing the name - surname of the director and CEO from Mr. Songwut Sakchalathorn to Mr. Trinnawat Thanitnithiphan effective from 23 September 2020.収支内訳Inter Pharma の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史SET:IP-R 収益、費用、利益 ( )THB Millions日付収益収益G+A経費研究開発費31 Mar 262,242133741031 Dec 252,214122729030 Sep 252,174111718030 Jun 252,05171689031 Mar 251,95846673031 Dec 241,91237650030 Sep 241,80711623030 Jun 241,80920607031 Mar 241,80927597031 Dec 231,79951568030 Sep 231,81591556030 Jun 231,775108540031 Mar 231,739128513031 Dec 221,534119458030 Sep 221,385130390030 Jun 221,226125339031 Mar 221,016118284031 Dec 21921105267030 Sep 2176068253030 Jun 2162663230031 Mar 2152656202031 Dec 2044753187030 Sep 2040862162030 Jun 2039057155031 Mar 2038956156031 Dec 1937643157030 Sep 1937128175030 Jun 1936527176031 Mar 1934324169031 Dec 1831830152031 Dec 1724816120031 Dec 1612516590質の高い収益: IP-Rは 高品質の収益 を持っています。利益率の向上: IP-Rの現在の純利益率 (5.9%)は、昨年(2.4%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: IP-Rの収益は過去 5 年間で年間3.1%減少しました。成長の加速: IP-Rの過去 1 年間の収益成長率 ( 186% ) は、5 年間の平均 ( 年間-3.1%を上回っています。収益対業界: IP-Rの過去 1 年間の収益成長率 ( 186% ) はPersonal Products業界6.4%を上回りました。株主資本利益率高いROE: IP-Rの 自己資本利益率 ( 6.3% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YHousehold 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/02 08:37終値2026/06/02 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Inter Pharma Public Company Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Mar 03Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026Inter Pharma Public Company Limited announced Annual dividend of THB 0.0730 per share payable on May 25, 2026, ex-date on May 06, 2026 and record date on May 07, 2026.
お知らせ • Mar 02Inter Pharma Public Company Limited, Annual General Meeting, Apr 27, 2026Inter Pharma Public Company Limited, Annual General Meeting, Apr 27, 2026, at 14:00 SE Asia Standard Time.
お知らせ • Feb 27Inter Pharma Public Company Limited Proposes to Omit Dividend Payment for the Year Ended December 31, 2024Inter Pharma Public Company Limited at its Annual General Meeting of Shareholders to be on April 26, 2024, proposed the allocation of net profit for the year ended December 31, 2024 amount of THB 1.2 Million as the Company's legal reserve and approve the omitted dividend payment for operating results in 2024 to be used as working capital of the Company.
お知らせ • Feb 26Inter Pharma Public Company Limited, Annual General Meeting, Apr 28, 2025Inter Pharma Public Company Limited, Annual General Meeting, Apr 28, 2025, at 14:00 SE Asia Standard Time.
お知らせ • Apr 27Inter Pharma Public Company Limited Approves Dividend for the Year 2023, Payable on May 24, 2024Inter Pharma Public Company Limited announced that at the AGM was held on April 26, 2024, the company approved the dividend payment in cash to shareholders at the rate of THB 0.0348 per share for the Year 2023. The Board also specified the date to determine the list of shareholders entitled to receive the dividend as May 8, 2024 (Record Date), with dividend payments scheduled on May 24, 2024.
お知らせ • Mar 01+ 1 more updateInter Pharma Public Company Limited Proposes Dividend for the Year 2023, Payable on May 24, 2024Inter Pharma Public Company Limited proposed at its AGM to be held on April 26, 2024 to approve The dividend payment in cash to shareholders at the rate of THB 0.0348 per share, totalling not exceeding THB 12,963,714.2352. The Board also specified the date to determine the list of shareholders entitled to receive the dividend as May 8, 2024 (Record Date), with dividend payments scheduled on May 24, 2024.
お知らせ • Jun 28+ 1 more updateInter Pharma Public Company Limited Announces CFO ChangesInter Pharma Public Company Limited announced the resignation of Mrs. Nattarin Polpuech as CFO effective June 23, 2023. The company also appointed Miss Chatkaew Krudkosol as Acting Chief Financial Officer effective June 23, 2023.
お知らせ • Dec 03Inter Pharma Public Company Limited Announces Resignation of Terdkiat Prommool as DirectorInter Pharma Public Company Limited announced that Mr. Terdkiat Prommool has resigned from the Director of the Company due to his other business engagement, effective from December 1, 2022 onwards.
お知らせ • Aug 11+ 1 more updateInter Pharma Public Company Limited announced that it has received THB 1.04314 billion in funding from Innobic LL Holding Company LimitedOn August 10, 2022 Inter Pharma Public Company Limited closed the transaction. The company issued 4,510,000 shares at a price of THB 14 each share for the gross proceeds of THB 1,043,140,000 to Innobic LL Holding Company Limited.
お知らせ • Jul 22Inter Pharma Public Company Limited Approves Election of DirectorsInter Pharma Public Company Limited approved the appointment of Mrs. Apimon Posri, Mrs. Nattarin Polpuech and Ms. Chompunuch Meevang as Director, at the EGM held on July 20, 2022.
お知らせ • Jul 05Inter Pharma Public Company Limited Announces Chief Financial Officer ChangesInter Pharma Public Company Limited announced that Ms. Supaporn Rerkpitakpanich, the former position of Chief Financial Officer has been changed to Group Accounting & Finance Director and will be responsible for the accounting and finance of the Group of Company. Also, Mrs. Nattarin Polpuech, former position Finance Manager will be replacing Ms. Supaporn's and become Chief Financial Officer, effective July 1, 2022 onwards.
お知らせ • Feb 26+ 1 more updateInter Pharma Public Company Limited Proposes Omission of Dividend Payment for 2021of dividend payment approved to propose to the Shareholders' Meeting to consider and approve the omission of dividend payment for the operating results of the year 2021, due to the Company has plan for business expansion. Therefore, reserves must be set aside to support the expansion plan in order to create sustainable growth for the Company.
お知らせ • Apr 27Inter Pharma Public Company Limited Approves Cash Dividends for 2020, Payable on May 18, 2020Inter Pharma Public Company Limited will pay cash dividends instead of stock dividend at the rate of THB 0.2234 per share. The record date for Dividend is set out on March 12, 2021 and the dividend will be paid on May 18, 2021.
お知らせ • Feb 26Inter Pharma Public Company Limited, Annual General Meeting, Apr 26, 2021Inter Pharma Public Company Limited, Annual General Meeting, Apr 26, 2021, at 08:00 Coordinated Universal Time. Agenda: To certify the minutes of the Extraordinary General Meeting of Shareholders No. 1/2020; to acknowledge the issuance and offering of debentures in the amount not exceeding THB 300 million, provided the total debt burden of the Company at any given time must not exceed the amount of THB 460 million; to consider and approve the increase in the Company's registered capital to support the stock dividend payment; to consider and approve an amendment to Clause 4 of the Company's Memorandum of Association to reflect the increase in registered capital; to consider and approve the appointment of directors replacing those due to retire by rotation; to consider and approve the remuneration of directors for the year 2021; to consider and approve the appointment and remuneration of auditors for the year 2021; and to consider other matters (if any) e for 2021 Annual General of shareholder's Meeting is scheduled on April 12th, 2021. med accordingly,.
お知らせ • Feb 10+ 1 more updateInter Pharma Public Company Limited (SET:IP) entered into an agreement to acquire Certain Assets of Teva Pharma (Thailand) Co., Ltd. from Teva Pharma (Thailand) Co., Ltd. for THB 160 million.Inter Pharma Public Company Limited (SET:IP) entered into an agreement to acquire Certain Assets of Teva Pharma (Thailand) Co., Ltd. from Teva Pharma (Thailand) Co., Ltd. for THB 160 million on February 8, 2021.
お知らせ • Jan 31Inter Pharma Public Company Limited Notifies the Resignation of Mr. Amornsakdi Ketcharoon from Independent Director, Audit Committee, Chairman of the Nomination and Remuneration Committee and Corporate Governance and Sustainable Development Committee ,Effective from January 31, 2021Inter Pharma Public Company Limited notified the resignation of Mr. Amornsakdi Ketcharoon from Independent Director, Audit Committee, Chairman of the Nomination and Remuneration Committee and Corporate Governance and Sustainable Development Committee because of the individual duties. The resignation will be effective from January 31, 2021 onwards.
お知らせ • Sep 26+ 1 more updateInterpharma Public Company Limited Announces Director ChangesInterpharma Public Company Limited announced the changing the name - surname of the director and CEO from Mr. Songwut Sakchalathorn to Mr. Trinnawat Thanitnithiphan effective from 23 September 2020.